MPR for Stroke Risk Assessment of ICAS

NCT07309718 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

ICAS - Intracranial Atherosclerosis
Stroke Ischemic
Hemodynamic

Interventions

DRUG: Standardized medical therapy targeting vascular risk factors and stroke prevention

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]